[1]Zhang X,Zhang X,Sun B,et al.Detection of aberrant promoter methylation of RNF180,DAPK1 and SFRP2 in plasma DNA of patients with gastric cancer[J].Oncol Lett,2014,8(4):1745-1750.
[2]Fitzmaurice C,Dicker D,Pain A,et al.The global burden of cancer 2013[J].JAMA Oncol,2015,1:505-527.
[3]Sanjay Koul,James M McKiernan,Gopeshwar Narayan,et al.Role of promoter hypermethylation in Cisplatin treatment response of male germ cell tumors[J].Molecular Cancer,2004,3:16.
[4]Dmitrijeva M,Ossowski S,Serrano L,et al.Tissue-specific DNA methylation loss during ageing and carcinogenesis is linked to chromosome structure,replication timing and cell division rates[J].Nucleic Acids Res,2018,10:1093.
[5]Qu Y,Dang S,Hou P.Gene methylation in gastric cancer[J].Clin Chim Acta,2013,424:53-65.
[6]How KA,Nielsen HM,Tost J.DNA methylation based biomarkers:Practical considerations and applications[J].Biochimie,2012,94:2314-2337.
[7]Clermont PL,Parolia A,Liu HH,et al.DNA methylation at enhancer regions:Novel avenues for epigenetic biomarker development[J].Front Biosci,2016,21(1):430-446.
[8]Hu W,Zheng W,Liu Q,et al.Diagnostic accuracy of DNA methylation in detection of gastric cancer:A Meta-analysis[J].Oncotarget,2017,8(68):113142-113152.
[9]Losi L,Fonda S,Saponaro S,et al.Distinct DNA methylation profiles in ovarian tumors:Opportunities for novel biomarkers[J].Int J Mol Sci,2018,19(6):E1559.
[10]Tahara T,Arisawa T.DNA methylation as a molecular biomarker in gastric cancer[J].Epigenomics,2015,7(3):475-486.
[11]Yu Y,Cao H,Zhang M.Prognostic value of DNA methylation for bladder cancer[J].Clin Chim Acta,2018,484:207-212.
[12]Feng C,Dong J,Chang W,et al.The progress of methylation regulation in gene expression of cervical cancer[J].Int J Genomics,2018,2018(2):1-11.
[13]Sood S,Patel FD,Srinivasan R,et al.Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer[J].Indian J Med Res,2018,147(2):151-157.
[14]Chi HC,Tsai CY,Tsai MM,et al.Impact of DNA and RNA methylation on radiobiology and cancer progression[J].Int J Mol Sci,2018,19(2):E555.
[15]Liu G,Liu YJ,Lian WJ,et al.Reduced BMP6 expression by DNA methylation contributes to EMT and drug resistance in breast cancer cells[J].Oncol Rep,2014,32(2):581-588.
[16]Gampenrieder SP,Rinnerthaler G,Hackl H,et al.DNA methylation signatures predicting bevacizumab efficacy in metastatic breast cancer[J].Theranostics,2018,8(8):2278-2288.